Edward Hu
Chief Investment Officer at WUXI APPTEC CO., LTD.
Net worth: 2 M $ as of 2024-03-30
Profile
Edward Hu founded 6 Dimensions Capital. He is Vice Chairman & Chief Investment Officer at WuXi AppTec Co., Ltd. and Vice Chairman & Global Chief Investment Officer at Wuxi Apptec, Inc. (a subsidiary of WuXi AppTec Co., Ltd.), Chief Financial & Investment Officer at Wuxi PharmaTech (Cayman) Inc. Founding Partner of 6 Dimensions Capital which he founded. Edward Hu is also on the board of 11 other companies. In his past career he was Senior Financial Analyst at Merck & Co., Inc., Manager-Financial Planning & Business Analysis at Biogen, Inc. and Chief Operating Officer & Senior Vice President of Tanox, Inc. He received an MBA and a graduate degree from Carnegie Mellon University and an undergraduate degree from Zhejiang University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-03-31 | 283,314 ( 0.01% ) | 2 M $ | 2024-03-30 | |
2024-03-25 | 91,433 ( 0.02% ) | 433 424 $ | 2024-03-30 | |
CSTONE PHARMACEUTICALS
-.--% | 2024-03-27 | 0 ( -.--% ) | - $ | 2024-03-30 |
Edward Hu active positions
Companies | Position | Start |
---|---|---|
WUXI APPTEC CO., LTD. | Chief Investment Officer | 2016-03-22 |
CSTONE PHARMACEUTICALS | Director/Board Member | 2021-07-08 |
CANBRIDGE PHARMACEUTICALS INC. | Director/Board Member | 2022-07-04 |
Wuxi New Life Science Investment Ltd.
Wuxi New Life Science Investment Ltd. Financial ConglomeratesFinance Wuxi New Life Science Investment Ltd. is a Chinese company that provides investment services. The private company is based in Shanghai, China. | Director/Board Member | - |
Phagelux, Inc.
Phagelux, Inc. BiotechnologyHealth Technology Phagelux, Inc. develops anti-bacterial solutions. It specializes across multiple fields utilizing various phage and phage-based technologies and solutions. The company is headquartered in Shanghai, China. | Director/Board Member | - |
Hua Medtech Medical Devices (Shanghai) Co., Ltd.
Hua Medtech Medical Devices (Shanghai) Co., Ltd. Medical SpecialtiesHealth Technology Hua Medtech Medical Devices (Shanghai) Co., Ltd. provides stroke diagnosis, treatment, and rehabilitation services. The private company is based in Shanghai, China. The Chinese company was founded in 2017. Wei Zhang has been the CEO of the company since 2020. | Director/Board Member | 2020-04-02 |
Wuxi Apptec, Inc.
Wuxi Apptec, Inc. Data Processing ServicesTechnology Services Wuxi Apptec, Inc. provides pharmaceutical and biotechnology services. Its services include discovery, lab testing division, small molecule pharmaceutical development and manufacturing international discovery service unit, WuXi biologics, chemistry, bioanalytical, clinical & regulatory, genome center, biological reagents and WuXi venture fund. The company was founded by Ge Li in December 2000 and is headquartered in St. Paul, MN. | Chief Investment Officer | 2017-02-28 |
WuXi Apptec UK Ltd.
WuXi Apptec UK Ltd. Miscellaneous Commercial ServicesCommercial Services Part of WuXi AppTec Co., Ltd., WuXi Apptec UK Ltd. is a private company that engages in technical testing, analysis, and provides research and experimental development on biotechnology. The company is based in London, UK and was founded in 2011. | Director/Board Member | 2018-11-15 |
Shanghai Syn-the-all Pharmaceutical Co. Ltd.
Shanghai Syn-the-all Pharmaceutical Co. Ltd. Pharmaceuticals: GenericHealth Technology Shanghai Syn-the-all Pharmaceutical Co. Ltd. engages in the manufacture, research and development of generic drugs. The company offers active pharmaceutical ingredients and finished forms. It provides API process development, small molecule Active pharmaceutical ingredients, analytical development and quality control, antibody drug conjugate services. It serves life science industry. Shanghai Syn-the-all Pharmaceutical was founded on January 23, 2003 and is headquartered in Shanghai, China. | Director/Board Member | 2017-11-01 |
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░░ ░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Former positions of Edward Hu
Companies | Position | End |
---|---|---|
░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░ ░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Edward Hu
Carnegie Mellon University | Graduate Degree |
Zhejiang University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 7 |
---|---|
MERCK & CO., INC. | Health Technology |
BIOGEN INC. | Health Technology |
WUXI APPTEC CO., LTD. | Health Technology |
IDEAYA BIOSCIENCES, INC. | Health Technology |
CSTONE PHARMACEUTICALS | Health Technology |
WUXI BIOLOGICS (CAYMAN) INC. | Health Technology |
CANBRIDGE PHARMACEUTICALS INC. | Health Technology |
Private companies | 20 |
---|---|
Tanox, Inc.
Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Health Technology |
Wuxi PharmaTech (Cayman), Inc.
Wuxi PharmaTech (Cayman), Inc. Pharmaceuticals: MajorHealth Technology Wuxi PharmaTech (Cayman), Inc. engages in the provision of research and development outsourcing services for the pharmaceutical, biotechnology and medical device industries. It operates through the laboratory services and manufacturing services segments. The laboratory services segment offers pharmaceutical and biotech services including discovery and medicinal chemistry, discovery biology, safety pharmacology, bioanalytical services, process research, formulation and toxicology laboratory services, as well as testing services for biologics, medical devices and combination products. The manufacturing services segment involves the production of intermediates and active pharmaceutical ingredients for or preclinical and clinical trials of small-molecule and commercial products; and biologics. The company was founded by Ge Li, Xiao Zhong Liu, Zhao Hui Zhang and Ning Zhao in 2000 and is headquartered in Shanghai, China. | Health Technology |
Callidus Biopharma, Inc.
Callidus Biopharma, Inc. BiotechnologyHealth Technology Callidus Biopharma, Inc. develops drug discovery services. The firm focuses on enzyme replacement therapies (ERTs) for lysosomal storage disorders (LSDs). Its novel technology platform is based on attaching a form of the naturally occurring Insulin-like growth factor (IGF-2) to enhance the targeting of therapeutic enzymes to the relevant cells in the body. The company was founded by Cuong Viet Do and Hung Do in 2010 and is headquartered in Bensalem, PA. | Health Technology |
Vivace Therapeutics, Inc.
Vivace Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vivace Therapeutics, Inc. discovers and develops novel cancer drug. The company was founded by Shuang Qiao in 2014 and is headquartered in San Mateo, CA. | Health Technology |
Ambrx, Inc.
Ambrx, Inc. Pharmaceuticals: MajorHealth Technology Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA. | Health Technology |
Shanghai Syn-the-all Pharmaceutical Co. Ltd.
Shanghai Syn-the-all Pharmaceutical Co. Ltd. Pharmaceuticals: GenericHealth Technology Shanghai Syn-the-all Pharmaceutical Co. Ltd. engages in the manufacture, research and development of generic drugs. The company offers active pharmaceutical ingredients and finished forms. It provides API process development, small molecule Active pharmaceutical ingredients, analytical development and quality control, antibody drug conjugate services. It serves life science industry. Shanghai Syn-the-all Pharmaceutical was founded on January 23, 2003 and is headquartered in Shanghai, China. | Health Technology |
6 Dimensions Capital
6 Dimensions Capital Investment ManagersFinance 6 Dimensions Capital is an independent private equity firm headquartered in China. The firm was founded in 2017. | Finance |
Wuxi Apptec, Inc.
Wuxi Apptec, Inc. Data Processing ServicesTechnology Services Wuxi Apptec, Inc. provides pharmaceutical and biotechnology services. Its services include discovery, lab testing division, small molecule pharmaceutical development and manufacturing international discovery service unit, WuXi biologics, chemistry, bioanalytical, clinical & regulatory, genome center, biological reagents and WuXi venture fund. The company was founded by Ge Li in December 2000 and is headquartered in St. Paul, MN. | Technology Services |
TenNor Therapeutics Suzhou Ltd.
TenNor Therapeutics Suzhou Ltd. Pharmaceuticals: GenericHealth Technology TenNor Therapeutics Suzhou Ltd. manufactures pharmaceutical products. It specializes in research and development of new drugs for the treatment of digestive diseases caused by pathogens, including those resistant to available antibiotics. The company was founded by Zhen Kun Ma in 2013 and is headquartered in Suzhou, China. | Health Technology |
JW Biotechnology (Shanghai) Co. Ltd. | |
LifeMine Therapeutics, Inc.
LifeMine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LifeMine Therapeutics, Inc. develops drugs from fungi which aims to cure untreatable and significant chronic diseases. The company was founded by Gregory L. Verdine, WeiQing Zhou, Richard D. Klausner and Hingge Hsu and is headquartered in Cambridge, MA. | Health Technology |
Wuxi Biologics Holdings Ltd.
Wuxi Biologics Holdings Ltd. Financial ConglomeratesFinance Wuxi Biologics Holdings Ltd. functions as an investment holding There is no available country named vg company. | Finance |
Wuxi New Life Science Investment Ltd.
Wuxi New Life Science Investment Ltd. Financial ConglomeratesFinance Wuxi New Life Science Investment Ltd. is a Chinese company that provides investment services. The private company is based in Shanghai, China. | Finance |
Viela Bio, Inc.
Viela Bio, Inc. BiotechnologyHealth Technology Viela Bio, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatment for autoimmune and inflammatory diseases. The firms product candidate includes inebilizumab, which is a humanized monoclonal antibody (mAb), designed to target CD19, a molecule expressed on the surface of a broad range of immune system B cells; VIB4920, which is a fusion protein designed to bind to CD40L on activated T cells, blocking their interaction with CD40-expressing B cells and potentially other binding partners; and VIB7734, which is a humanized mAb intended to be a novel treatment for autoimmune diseases where the pathology is driven principally by overproduction of type I interferons and other cytokines secreted by pDCs. The company was founded on December 11, 2017 and is headquartered in Gaithersburg, MD. | Health Technology |
JW Therapeutics (Shanghai) Co., Ltd.
JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology JW Therapeutics (Shanghai) Co., Ltd. engages in biopharmaceutical industry. It focuses on the development, transformation, and promotion of cell-based immunotherapies to treat cancer. The company was founded by Yi Ping Li on February 18, 2016 and is headquartered in Shanghai, China. | Health Technology |
WuXi Apptec UK Ltd.
WuXi Apptec UK Ltd. Miscellaneous Commercial ServicesCommercial Services Part of WuXi AppTec Co., Ltd., WuXi Apptec UK Ltd. is a private company that engages in technical testing, analysis, and provides research and experimental development on biotechnology. The company is based in London, UK and was founded in 2011. | Commercial Services |
Hua Medtech Medical Devices (Shanghai) Co., Ltd.
Hua Medtech Medical Devices (Shanghai) Co., Ltd. Medical SpecialtiesHealth Technology Hua Medtech Medical Devices (Shanghai) Co., Ltd. provides stroke diagnosis, treatment, and rehabilitation services. The private company is based in Shanghai, China. The Chinese company was founded in 2017. Wei Zhang has been the CEO of the company since 2020. | Health Technology |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Health Technology |
Suzhou Borui Chuanghe Pharmaceutical Co., Ltd.
Suzhou Borui Chuanghe Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Suzhou Borui Chuanghe Pharmaceutical Co., Ltd. is a company based in Suzhou, China that provides research and development solutions for radionuclide-targeted drugs. The Chinese company was founded in 2018 and the CEO is Jiang Bin Hu. | Commercial Services |
Phagelux, Inc.
Phagelux, Inc. BiotechnologyHealth Technology Phagelux, Inc. develops anti-bacterial solutions. It specializes across multiple fields utilizing various phage and phage-based technologies and solutions. The company is headquartered in Shanghai, China. | Health Technology |
- Stock Market
- Insiders
- Edward Hu